| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | 3'-5'-RNA exonuclease activity | 8.99e-04 | 37 | 24 | 2 | GO:0000175 | |
| GeneOntologyMolecularFunction | RNA exonuclease activity, producing 5'-phosphomonoesters | 1.05e-03 | 40 | 24 | 2 | GO:0016896 | |
| GeneOntologyMolecularFunction | RNA exonuclease activity | 1.33e-03 | 45 | 24 | 2 | GO:0004532 | |
| GeneOntologyMolecularFunction | 3'-5' exonuclease activity | 2.43e-03 | 61 | 24 | 2 | GO:0008408 | |
| GeneOntologyMolecularFunction | exonuclease activity, active with either ribo- or deoxyribonucleic acids and producing 5'-phosphomonoesters | 2.51e-03 | 62 | 24 | 2 | GO:0016796 | |
| GeneOntologyMolecularFunction | exonuclease activity | 5.43e-03 | 92 | 24 | 2 | GO:0004527 | |
| GeneOntologyCellularComponent | apical junction complex | 2.97e-05 | 158 | 24 | 4 | GO:0043296 | |
| GeneOntologyCellularComponent | zonula adherens | 3.52e-05 | 8 | 24 | 2 | GO:0005915 | |
| GeneOntologyCellularComponent | cell-cell junction | 4.34e-05 | 591 | 24 | 6 | GO:0005911 | |
| GeneOntologyCellularComponent | cytoplasmic exosome (RNase complex) | 1.50e-04 | 16 | 24 | 2 | GO:0000177 | |
| GeneOntologyCellularComponent | exosome (RNase complex) | 3.43e-04 | 24 | 24 | 2 | GO:0000178 | |
| GeneOntologyCellularComponent | exoribonuclease complex | 4.36e-04 | 27 | 24 | 2 | GO:1905354 | |
| GeneOntologyCellularComponent | anchoring junction | 6.65e-04 | 976 | 24 | 6 | GO:0070161 | |
| GeneOntologyCellularComponent | adherens junction | 1.78e-03 | 212 | 24 | 3 | GO:0005912 | |
| MousePheno | abnormal ventral pancreas morphology | 1.05e-05 | 4 | 19 | 2 | MP:0013867 | |
| MousePheno | abnormal ductus venosus valve morphology | 3.77e-05 | 49 | 19 | 3 | MP:0013877 | |
| MousePheno | retrolental blood | 6.27e-05 | 9 | 19 | 2 | MP:0014087 | |
| MousePheno | abnormal ductus venosus morphology | 6.27e-05 | 58 | 19 | 3 | MP:0013873 | |
| MousePheno | abnormal inferior vena cava morphology | 1.01e-04 | 68 | 19 | 3 | MP:0006063 | |
| MousePheno | abnormal vena cava morphology | 1.46e-04 | 77 | 19 | 3 | MP:0006062 | |
| MousePheno | abnormal oculomotor nerve morphology | 1.58e-04 | 14 | 19 | 2 | MP:0001061 | |
| MousePheno | abnormal cervical rib | 2.08e-04 | 16 | 19 | 2 | MP:0008922 | |
| MousePheno | abnormal intestine placement | 2.64e-04 | 18 | 19 | 2 | MP:0014023 | |
| MousePheno | thoracoschisis | 2.64e-04 | 18 | 19 | 2 | MP:0008923 | |
| MousePheno | abnormal optic chiasm morphology | 3.28e-04 | 20 | 19 | 2 | MP:0009770 | |
| MousePheno | heterochrony | 4.35e-04 | 23 | 19 | 2 | MP:0014021 | |
| MousePheno | bicuspid aortic valve | 5.15e-04 | 25 | 19 | 2 | MP:0010484 | |
| MousePheno | abnormal optic stalk morphology | 7.44e-04 | 30 | 19 | 2 | MP:0004268 | |
| MousePheno | absent ductus venosus valve | 7.95e-04 | 31 | 19 | 2 | MP:0013876 | |
| MousePheno | increased lung adenoma incidence | 9.01e-04 | 33 | 19 | 2 | MP:0002048 | |
| MousePheno | abnormal lung adenoma incidence | 9.01e-04 | 33 | 19 | 2 | MP:0020190 | |
| MousePheno | abnormal pancreas development | 1.01e-03 | 35 | 19 | 2 | MP:0003934 | |
| MousePheno | abnormal body wall morphology | 1.05e-03 | 151 | 19 | 3 | MP:0003385 | |
| Domain | PHD | 4.15e-03 | 75 | 24 | 2 | PF00628 | |
| Domain | Znf_PHD-finger | 4.59e-03 | 79 | 24 | 2 | IPR019787 | |
| Domain | PHD | 5.79e-03 | 89 | 24 | 2 | SM00249 | |
| Domain | Znf_PHD | 6.04e-03 | 91 | 24 | 2 | IPR001965 | |
| Domain | ZF_PHD_2 | 6.57e-03 | 95 | 24 | 2 | PS50016 | |
| Domain | ZF_PHD_1 | 6.70e-03 | 96 | 24 | 2 | PS01359 | |
| Domain | Znf_FYVE_PHD | 1.52e-02 | 147 | 24 | 2 | IPR011011 | |
| Pathway | REACTOME_CROSSLINKING_OF_COLLAGEN_FIBRILS | 1.60e-04 | 18 | 15 | 2 | M27164 | |
| Pathway | REACTOME_CROSSLINKING_OF_COLLAGEN_FIBRILS | 1.60e-04 | 18 | 15 | 2 | MM14882 | |
| Pathway | REACTOME_MAJOR_PATHWAY_OF_RRNA_PROCESSING_IN_THE_NUCLEOLUS_AND_CYTOSOL | 8.32e-04 | 180 | 15 | 3 | MM15324 | |
| Pathway | WP_MIRNA_TARGETS_IN_ECM_AND_MEMBRANE_RECEPTORS | 9.31e-04 | 43 | 15 | 2 | M39565 | |
| Pathway | REACTOME_RRNA_PROCESSING | 1.21e-03 | 205 | 15 | 3 | M27685 | |
| Pathway | REACTOME_ASSEMBLY_OF_COLLAGEN_FIBRILS_AND_OTHER_MULTIMERIC_STRUCTURES | 1.26e-03 | 50 | 15 | 2 | MM14796 | |
| Pathway | KEGG_RNA_DEGRADATION | 1.75e-03 | 59 | 15 | 2 | M963 | |
| Pathway | REACTOME_ASSEMBLY_OF_COLLAGEN_FIBRILS_AND_OTHER_MULTIMERIC_STRUCTURES | 1.87e-03 | 61 | 15 | 2 | M27103 | |
| Pathway | REACTOME_EXTRACELLULAR_MATRIX_ORGANIZATION | 2.34e-03 | 258 | 15 | 3 | MM14572 | |
| Pathway | REACTOME_ECM_PROTEOGLYCANS | 2.88e-03 | 76 | 15 | 2 | M27219 | |
| Pathway | REACTOME_COLLAGEN_FORMATION | 2.88e-03 | 76 | 15 | 2 | MM14573 | |
| Pathway | REACTOME_METABOLISM_OF_RNA | 3.27e-03 | 612 | 15 | 4 | MM15547 | |
| Pathway | KEGG_ECM_RECEPTOR_INTERACTION | 3.50e-03 | 84 | 15 | 2 | M7098 | |
| Pathway | REACTOME_EXTRACELLULAR_MATRIX_ORGANIZATION | 3.59e-03 | 300 | 15 | 3 | M610 | |
| Pathway | WP_FOCAL_ADHESION_PI3KAKTMTORSIGNALING | 3.66e-03 | 302 | 15 | 3 | M39719 | |
| Pathway | REACTOME_COLLAGEN_FORMATION | 4.01e-03 | 90 | 15 | 2 | M631 | |
| Pathway | WP_FOCAL_ADHESION_PI3KAKTMTOR_SIGNALING_PATHWAY | 4.54e-03 | 326 | 15 | 3 | MM15917 | |
| Pathway | WP_PI3KAKT_SIGNALING | 5.06e-03 | 339 | 15 | 3 | M39736 | |
| Pubmed | Large-scale characterization of HeLa cell nuclear phosphoproteins. | 3.11e-08 | 774 | 24 | 8 | 15302935 | |
| Pubmed | A protein-RNA interaction atlas of the ribosome biogenesis factor AATF. | 8.15e-08 | 162 | 24 | 5 | 31363146 | |
| Pubmed | Identification of a USP9X Substrate NFX1-123 by SILAC-Based Quantitative Proteomics. | 1.98e-07 | 384 | 24 | 6 | 31059266 | |
| Pubmed | 3.78e-07 | 713 | 24 | 7 | 29802200 | ||
| Pubmed | 7.15e-07 | 251 | 24 | 5 | 28077445 | ||
| Pubmed | 9.58e-07 | 503 | 24 | 6 | 16964243 | ||
| Pubmed | 1.56e-06 | 547 | 24 | 6 | 37267103 | ||
| Pubmed | Direct interaction between hnRNP-M and CDC5L/PLRG1 proteins affects alternative splice site choice. | 2.23e-06 | 582 | 24 | 6 | 20467437 | |
| Pubmed | 2.74e-06 | 4 | 24 | 2 | 36438572 | ||
| Pubmed | 3.49e-06 | 347 | 24 | 5 | 15231747 | ||
| Pubmed | 3.49e-06 | 347 | 24 | 5 | 17114649 | ||
| Pubmed | 4.32e-06 | 653 | 24 | 6 | 22586326 | ||
| Pubmed | Global phosphoproteome of HT-29 human colon adenocarcinoma cells. | 9.15e-06 | 59 | 24 | 3 | 16083285 | |
| Pubmed | The E3 ubiquitin ligase HECTD1 contributes to cell proliferation through an effect on mitosis. | 1.02e-05 | 759 | 24 | 6 | 35915203 | |
| Pubmed | Targeting USP10 induces degradation of oncogenic ANLN in esophageal squamous cell carcinoma. | 1.60e-05 | 1257 | 24 | 7 | 36526897 | |
| Pubmed | Poly(ADP-ribosyl)ation of BRD7 by PARP1 confers resistance to DNA-damaging chemotherapeutic agents. | 1.78e-05 | 486 | 24 | 5 | 30940648 | |
| Pubmed | Docking motif-guided mapping of the interactome of protein phosphatase-1. | 2.29e-05 | 80 | 24 | 3 | 19389623 | |
| Pubmed | 2.94e-05 | 916 | 24 | 6 | 32203420 | ||
| Pubmed | 3.00e-05 | 12 | 24 | 2 | 14527413 | ||
| Pubmed | 3.25e-05 | 551 | 24 | 5 | 34728620 | ||
| Pubmed | 3.54e-05 | 274 | 24 | 4 | 34244482 | ||
| Pubmed | The Nse5/6-like SIMC1-SLF2 complex localizes SMC5/6 to viral replication centers. | 3.70e-05 | 954 | 24 | 6 | 36373674 | |
| Pubmed | 4.08e-05 | 971 | 24 | 6 | 33306668 | ||
| Pubmed | Enoyl-CoA hydratase-1 regulates mTOR signaling and apoptosis by sensing nutrients. | 4.13e-05 | 14 | 24 | 2 | 28878358 | |
| Pubmed | 4.88e-05 | 103 | 24 | 3 | 10819331 | ||
| Pubmed | STING-Mediated IFI16 Degradation Negatively Controls Type I Interferon Production. | 6.16e-05 | 316 | 24 | 4 | 31665637 | |
| Pubmed | 6.27e-05 | 1049 | 24 | 6 | 27880917 | ||
| Pubmed | LGALS3BP regulates centriole biogenesis and centrosome hypertrophy in cancer cells. | 6.56e-05 | 639 | 24 | 5 | 23443559 | |
| Pubmed | 6.94e-05 | 18 | 24 | 2 | 19116923 | ||
| Pubmed | 6.94e-05 | 18 | 24 | 2 | 19143821 | ||
| Pubmed | 7.37e-05 | 655 | 24 | 5 | 35819319 | ||
| Pubmed | C16orf72/HAPSTR1 is a molecular rheostat in an integrated network of stress response pathways. | 7.50e-05 | 119 | 24 | 3 | 35776542 | |
| Pubmed | 9.51e-05 | 21 | 24 | 2 | 21408207 | ||
| Pubmed | ATG5 is required for B cell polarization and presentation of particulate antigens. | 1.01e-04 | 701 | 24 | 5 | 30196744 | |
| Pubmed | Ubiquitin-Independent Disassembly by a p97 AAA-ATPase Complex Drives PP1 Holoenzyme Formation. | 1.03e-04 | 361 | 24 | 4 | 30344098 | |
| Pubmed | 1.13e-04 | 1168 | 24 | 6 | 19946888 | ||
| Pubmed | 1.23e-04 | 731 | 24 | 5 | 29298432 | ||
| Pubmed | Parent-of-origin-specific allelic associations among 106 genomic loci for age at menarche. | 1.46e-04 | 149 | 24 | 3 | 25231870 | |
| Pubmed | 1.80e-04 | 160 | 24 | 3 | 31678930 | ||
| Pubmed | The mRNA-bound proteome and its global occupancy profile on protein-coding transcripts. | 1.96e-04 | 807 | 24 | 5 | 22681889 | |
| Pubmed | 2.24e-04 | 32 | 24 | 2 | 26142281 | ||
| Pubmed | The human cytoplasmic dynein interactome reveals novel activators of motility. | 2.53e-04 | 853 | 24 | 5 | 28718761 | |
| Pubmed | Analysis of the Histone H3.1 Interactome: A Suitable Chaperone for the Right Event. | 2.63e-04 | 182 | 24 | 3 | 26527279 | |
| Pubmed | 2.80e-04 | 469 | 24 | 4 | 27634302 | ||
| Pubmed | 3.13e-04 | 483 | 24 | 4 | 36912080 | ||
| Pubmed | Assembly of the U5 snRNP component PRPF8 is controlled by the HSP90/R2TP chaperones. | 3.21e-04 | 1415 | 24 | 6 | 28515276 | |
| Pubmed | 3.46e-04 | 496 | 24 | 4 | 31343991 | ||
| Pubmed | Fibril treatment changes protein interactions of tau and α-synuclein in human neurons. | 3.52e-04 | 498 | 24 | 4 | 36634849 | |
| Pubmed | Defining the Protein-Protein Interaction Network of the Human Protein Tyrosine Phosphatase Family. | 3.78e-04 | 931 | 24 | 5 | 27432908 | |
| Pubmed | Mechanistic insights into COVID-19 by global analysis of the SARS-CoV-2 3CLpro substrate degradome. | 4.05e-04 | 43 | 24 | 2 | 34672947 | |
| Pubmed | TBK1 phosphorylation activates LIR-dependent degradation of the inflammation repressor TNIP1. | 4.13e-04 | 949 | 24 | 5 | 36574265 | |
| Pubmed | 4.42e-04 | 963 | 24 | 5 | 28671696 | ||
| Pubmed | 4.77e-04 | 223 | 24 | 3 | 33731348 | ||
| Pubmed | Comprehensive identification of phosphorylation sites in postsynaptic density preparations. | 5.28e-04 | 231 | 24 | 3 | 16452087 | |
| Pubmed | Novel skin phenotypes revealed by a genome-wide mouse reverse genetic screen. | 5.48e-04 | 50 | 24 | 2 | 24721909 | |
| Pubmed | Mapping the NPHP-JBTS-MKS protein network reveals ciliopathy disease genes and pathways. | 5.62e-04 | 564 | 24 | 4 | 21565611 | |
| Pubmed | Identifying biological pathways that underlie primordial short stature using network analysis. | 5.84e-04 | 1024 | 24 | 5 | 24711643 | |
| Pubmed | 6.26e-04 | 245 | 24 | 3 | 19521500 | ||
| Pubmed | 6.34e-04 | 246 | 24 | 3 | 15345747 | ||
| Pubmed | The Tumor Suppressor CIC Directly Regulates MAPK Pathway Genes via Histone Deacetylation. | 6.36e-04 | 583 | 24 | 4 | 29844126 | |
| Pubmed | Genome-wide CRISPR screens identify novel regulators of wild-type and mutant p53 stability. | 6.57e-04 | 588 | 24 | 4 | 38580884 | |
| Pubmed | 6.63e-04 | 55 | 24 | 2 | 14656967 | ||
| Pubmed | 6.72e-04 | 251 | 24 | 3 | 29778605 | ||
| Interaction | PYHIN1 interactions | 3.09e-06 | 358 | 24 | 6 | int:PYHIN1 | |
| Interaction | PNMA2 interactions | 1.01e-05 | 251 | 24 | 5 | int:PNMA2 | |
| Interaction | XRN1 interactions | 1.15e-05 | 258 | 24 | 5 | int:XRN1 | |
| Interaction | NFX1 interactions | 1.40e-05 | 466 | 24 | 6 | int:NFX1 | |
| Interaction | KIF1B interactions | 4.87e-05 | 173 | 24 | 4 | int:KIF1B | |
| Interaction | FBXL6 interactions | 4.93e-05 | 583 | 24 | 6 | int:FBXL6 | |
| Interaction | DCAF7 interactions | 6.31e-05 | 368 | 24 | 5 | int:DCAF7 | |
| Interaction | EPPK1 interactions | 6.87e-05 | 189 | 24 | 4 | int:EPPK1 | |
| Interaction | AATF interactions | 6.98e-05 | 376 | 24 | 5 | int:AATF | |
| Interaction | NUP43 interactions | 7.25e-05 | 625 | 24 | 6 | int:NUP43 | |
| Interaction | HECTD1 interactions | 1.08e-04 | 984 | 24 | 7 | int:HECTD1 | |
| Interaction | SNRNP70 interactions | 1.08e-04 | 984 | 24 | 7 | int:SNRNP70 | |
| Interaction | USP16 interactions | 1.11e-04 | 79 | 24 | 3 | int:USP16 | |
| Interaction | NEK1 interactions | 1.33e-04 | 84 | 24 | 3 | int:NEK1 | |
| Interaction | IFI16 interactions | 1.51e-04 | 714 | 24 | 6 | int:IFI16 | |
| Interaction | SIRT7 interactions | 1.89e-04 | 744 | 24 | 6 | int:SIRT7 | |
| Interaction | DHPS interactions | 2.29e-04 | 101 | 24 | 3 | int:DHPS | |
| Interaction | MTREX interactions | 2.42e-04 | 262 | 24 | 4 | int:MTREX | |
| Interaction | CEP135 interactions | 2.79e-04 | 272 | 24 | 4 | int:CEP135 | |
| Interaction | DXO interactions | 2.82e-04 | 21 | 24 | 2 | int:DXO | |
| Interaction | VIM interactions | 2.87e-04 | 804 | 24 | 6 | int:VIM | |
| Interaction | HAPSTR1 interactions | 3.39e-04 | 829 | 24 | 6 | int:HAPSTR1 | |
| Interaction | CDC5L interactions | 4.00e-04 | 855 | 24 | 6 | int:CDC5L | |
| Interaction | CPLANE1 interactions | 4.01e-04 | 25 | 24 | 2 | int:CPLANE1 | |
| Interaction | RBM7 interactions | 4.39e-04 | 126 | 24 | 3 | int:RBM7 | |
| Interaction | DDRGK1 interactions | 4.69e-04 | 1249 | 24 | 7 | int:DDRGK1 | |
| Interaction | RAB5B interactions | 4.70e-04 | 129 | 24 | 3 | int:RAB5B | |
| Interaction | ECT2 interactions | 4.86e-04 | 887 | 24 | 6 | int:ECT2 | |
| Interaction | MRPS34 interactions | 4.98e-04 | 317 | 24 | 4 | int:MRPS34 | |
| Interaction | UCHL5 interactions | 5.10e-04 | 319 | 24 | 4 | int:UCHL5 | |
| Interaction | GLDC interactions | 5.22e-04 | 321 | 24 | 4 | int:GLDC | |
| Interaction | OBSL1 interactions | 5.32e-04 | 902 | 24 | 6 | int:OBSL1 | |
| Interaction | ZNF286A interactions | 5.79e-04 | 30 | 24 | 2 | int:ZNF286A | |
| Interaction | MRPS27 interactions | 5.99e-04 | 333 | 24 | 4 | int:MRPS27 | |
| Interaction | YWHAZ interactions | 6.52e-04 | 1319 | 24 | 7 | int:YWHAZ | |
| Interaction | CPEB1 interactions | 6.74e-04 | 146 | 24 | 3 | int:CPEB1 | |
| Interaction | PARN interactions | 7.01e-04 | 148 | 24 | 3 | int:PARN | |
| Interaction | CSNK2A1 interactions | 7.23e-04 | 956 | 24 | 6 | int:CSNK2A1 | |
| Interaction | CSNK2B interactions | 7.35e-04 | 625 | 24 | 5 | int:CSNK2B | |
| Interaction | SNRNP40 interactions | 8.01e-04 | 637 | 24 | 5 | int:SNRNP40 | |
| Interaction | BRD7 interactions | 8.01e-04 | 637 | 24 | 5 | int:BRD7 | |
| Cytoband | 8q24.3 | 2.83e-05 | 113 | 24 | 3 | 8q24.3 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr8q24 | 8.23e-04 | 355 | 24 | 3 | chr8q24 | |
| Cytoband | 22q13.1 | 9.11e-04 | 85 | 24 | 2 | 22q13.1 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr6p21 | 2.23e-03 | 503 | 24 | 3 | chr6p21 | |
| Cytoband | 6p21.3 | 7.53e-03 | 250 | 24 | 2 | 6p21.3 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr22q13 | 1.28e-02 | 330 | 24 | 2 | chr22q13 | |
| GeneFamily | Armadillo repeat containing|Protein phosphatase 1 regulatory subunits | 2.03e-04 | 181 | 12 | 3 | 694 | |
| GeneFamily | PHD finger proteins | 1.57e-03 | 90 | 12 | 2 | 88 | |
| Coexpression | GSE3039_NKT_CELL_VS_B1_BCELL_UP | 3.04e-05 | 199 | 24 | 4 | M6432 | |
| Coexpression | GSE11924_TFH_VS_TH2_CD4_TCELL_UP | 3.10e-05 | 200 | 24 | 4 | M3153 | |
| ToppCell | 367C-Myeloid-Macrophage-SPP1+_Macrophage_2|Myeloid / Donor, Lineage, Cell class and subclass (all cells) | 6.19e-05 | 144 | 24 | 3 | 3ba7f8bd6d1c551048403c94693d63e60f7cbbb7 | |
| ToppCell | TCGA-Endometrium-Solid_Tissue_Normal-Endometrium_normal_tissue-Endometrium-7|TCGA-Endometrium / Sample_Type by Project: Shred V9 | 9.77e-05 | 168 | 24 | 3 | a97e8e07ba949b30805aeed5f60fa5e092b9d3d4 | |
| ToppCell | 368C-Myeloid-Macrophage-SPP1+_Macrophage_2|Macrophage / Donor, Lineage, Cell class and subclass (all cells) | 9.94e-05 | 169 | 24 | 3 | ea600c63cf9572bc4b3cad6392f67bd0d92c7fc9 | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Mesenchymal-Fibroblast-Collagen+matrisome-high_fibroblast|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 1.01e-04 | 170 | 24 | 3 | fa753cc8fbd04e63c9a303da4dc17ee2ce907f92 | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Mesenchymal-Fibroblast-Collagen+matrisome-high_fibroblast-|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 1.01e-04 | 170 | 24 | 3 | 03044e1436443b28dd39d5ef4fdb25c18e3a7546 | |
| ToppCell | TCGA-Endometrium-Solid_Tissue_Normal-Endometrium_normal_tissue-Endometrium|TCGA-Endometrium / Sample_Type by Project: Shred V9 | 1.01e-04 | 170 | 24 | 3 | cdc19013da7c41d1ed8400a6a643e4c684ff9912 | |
| ToppCell | TCGA-Endometrium-Solid_Tissue_Normal|TCGA-Endometrium / Sample_Type by Project: Shred V9 | 1.01e-04 | 170 | 24 | 3 | 0bde0a40440c7fdf7ba89cac8831d4014e7a4807 | |
| ToppCell | TCGA-Endometrium-Solid_Tissue_Normal-Endometrium_normal_tissue|TCGA-Endometrium / Sample_Type by Project: Shred V9 | 1.01e-04 | 170 | 24 | 3 | 516b38c4ecf6b0b04c5d4f80c510dcc00b328c6f | |
| ToppCell | droplet-Heart-4Chambers-18m-Endothelial-endothelial_cell_of_coronary_artery|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.16e-04 | 178 | 24 | 3 | 93ce73f8bcec63ebf86fabb546f88400e8f06465 | |
| ToppCell | 3'-Child09-12-SmallIntestine-Hematopoietic-T_cells-MAIT_cell|Child09-12 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.16e-04 | 178 | 24 | 3 | 0290868dc990878eac5c182fe64968333bc52450 | |
| ToppCell | COVID-19-Heart-VSMC|Heart / Disease (COVID-19 only), tissue and cell type | 1.18e-04 | 179 | 24 | 3 | a69ad6912b5c10bb9f9d800f724c792341e9bab1 | |
| ToppCell | PND03-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_vascular-Pericyte-Pericyte_mature|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.18e-04 | 179 | 24 | 3 | 56db12467b445f2b8ef92af50779eeab10413eb2 | |
| ToppCell | droplet-Lung-nan-18m-Mesenchymal-Pericyte|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.20e-04 | 180 | 24 | 3 | f6a05b3751b01e74b2de8440801b0eb2e723c199 | |
| ToppCell | droplet-Lung-nan-18m-Mesenchymal-pericyte_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.20e-04 | 180 | 24 | 3 | dfc75ae4395ff46fbec2c54915d98ead5a1ba1a1 | |
| ToppCell | droplet-Spleen-nan-18m|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.24e-04 | 182 | 24 | 3 | eeb5dfa4539e9ca5220f26bc2b65717ddcf13b6c | |
| ToppCell | droplet-Spleen-nan-18m-Lymphocytic|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.26e-04 | 183 | 24 | 3 | 28cbf909424f3be4491d49832f0aca0386560814 | |
| ToppCell | droplet-Spleen-nan-18m-Lymphocytic-nan|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.26e-04 | 183 | 24 | 3 | 3fa608aa6b119869ec3280dc388dfee57160e63a | |
| ToppCell | P28-Mesenchymal-developing_mesenchymal_cell-mesenchymal_myogenic_precursor_(Axin2+)|P28 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 1.28e-04 | 184 | 24 | 3 | 23c24ab5786af33d605bc445d06117b9da6c6331 | |
| ToppCell | facs-Lung-EPCAM-3m-Epithelial-Ciliated_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.34e-04 | 187 | 24 | 3 | 04dba2ed09ee4180830bdf0191921696697ea234 | |
| ToppCell | facs-Lung-EPCAM-3m-Epithelial-ciliated_columnar_cell_of_tracheobronchial_tree|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.34e-04 | 187 | 24 | 3 | 805dafe22f835ece4dd091d8030d0a63b52a48dd | |
| ToppCell | Influenza_Severe-RBC|World / Disease group and Cell class | 1.36e-04 | 188 | 24 | 3 | f0438e6a77ee1f0456cb65926685266fff470983 | |
| ToppCell | E18.5-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_vascular-Pericyte|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.36e-04 | 188 | 24 | 3 | a906c29e3fda22eecfec3e5cac706c417bf2b7a4 | |
| ToppCell | PND03-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_vascular-Pericyte|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.38e-04 | 189 | 24 | 3 | ca3a04c202afc32aa11d17154066ef7dc6d01405 | |
| ToppCell | E18.5-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_vascular-Pericyte-Pericyte_mature|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.41e-04 | 190 | 24 | 3 | 951e067d14412db67dc3babcdf61e41717d7b429 | |
| ToppCell | PND07-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_vascular-Pericyte-Pericyte_mature|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.41e-04 | 190 | 24 | 3 | 1004e89d99c9d46c78b7d3532d8d4aadb81a96fd | |
| ToppCell | PND07-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_vascular-Pericyte|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.41e-04 | 190 | 24 | 3 | 10b02c62e72bfea9767e3e751011436925da823e | |
| ToppCell | P07-Mesenchymal-developing_mesenchymal_cell-mesenchymal_myogenic_precursor_(Axin2+)|P07 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 1.43e-04 | 191 | 24 | 3 | 2ad717b59215ad8d933e9637d363b65d7298e5d4 | |
| ToppCell | Influenza_Severe-RBC|Influenza_Severe / Disease group and Cell class | 1.45e-04 | 192 | 24 | 3 | f19b6da3fd98da1a76d2570137a8f73a3850ebcb | |
| ToppCell | PND14-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_vascular-Pericyte|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.45e-04 | 192 | 24 | 3 | 158cc5736f154da1cb3186ffbf186eae10483e48 | |
| ToppCell | facs-Limb_Muscle-ForelimbandHindlimb-3m-Mesenchymal-mesenchymal_stem_cell|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.45e-04 | 192 | 24 | 3 | beac6b3c191b11add8e39e8d04562b478ea8929e | |
| ToppCell | PND14-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_vascular-Pericyte-Pericyte_mature|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.45e-04 | 192 | 24 | 3 | f4ff62ac9c53eafbe917706de9af8b2d4bded4d4 | |
| ToppCell | severe_influenza-RBC|severe_influenza / disease group, cell group and cell class (v2) | 1.47e-04 | 193 | 24 | 3 | ffb0b3c2cce13b6891157f0fede2600f3938670e | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Mesenchymal-Fibroblast-high_collagen-matrisome_fibroblast-|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 1.52e-04 | 195 | 24 | 3 | 803f714d91f2d97ecbee8c15a5139fd9310f66c7 | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Mesenchymal-Fibroblast-high_collagen-matrisome_fibroblast|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 1.52e-04 | 195 | 24 | 3 | 4f70157d42a16ff0259bc24a62803c4df4285c44 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Myocytic_interstitial_cell-Myofibroblast|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.54e-04 | 196 | 24 | 3 | 802f61e78a9a1030a86c4a980c398a73cd4d1574 | |
| ToppCell | facs-Aorta-Heart-3m-Mesenchymal-fibroblast_of_cardiac_tissue|Aorta / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.54e-04 | 196 | 24 | 3 | 2029f58ce6a7b8c35d3a7496c3341391990909ce | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Mesenchymal-Fibroblast|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 1.54e-04 | 196 | 24 | 3 | 2b36b9a40fe415917afccff99ad9c3474e087d0d | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Myocytic_interstitial_cell-Myofibroblast-|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.54e-04 | 196 | 24 | 3 | fa445f4240c521cf04eb2e2f79a5c55fda31209a | |
| ToppCell | Tracheal-NucSeq-Stromal-Schwann-Schwann_nonmyelinating|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.56e-04 | 197 | 24 | 3 | 5c88a97e8e23a5cd61885acbe1ef339ae6a1e35a | |
| ToppCell | Tracheal-NucSeq-Epithelial-Epi_submucosal-gland-Myoepithelial|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.56e-04 | 197 | 24 | 3 | f0475ad9c09c6da418dba17d3d3c1aaa2ef9ab4e | |
| ToppCell | Tracheal-NucSeq-Stromal-Schwann|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.56e-04 | 197 | 24 | 3 | c1b2a3fbd5f4aeb3555d8c372efc86f1052e7c65 | |
| ToppCell | Tracheal-NucSeq-Stromal-Myofibroblastic-Muscle_smooth_pulmonary|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.56e-04 | 197 | 24 | 3 | ac4f53acb2f8a428b0f2fab3c30a34e095a1bed7 | |
| ToppCell | Tracheal-NucSeq-Stromal-Myofibroblastic|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.59e-04 | 198 | 24 | 3 | c12e7511628db819a52959bb68580e27c00c2e41 | |
| ToppCell | Smart-start-Cell-Wel_seq-Neoplastic-Stem-like-OPC-like-OPC-like-E|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 1.59e-04 | 198 | 24 | 3 | 1847ce8c344c8a3e50f3cbbf758a38aba69f85b0 | |
| ToppCell | Tracheal-NucSeq-Stromal-Myofibroblastic-Muscle_smooth_airway_ASM|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.59e-04 | 198 | 24 | 3 | 22e766df1276c5b14aa0d83f434f47140ebb98ea | |
| ToppCell | Tracheal-NucSeq-Stromal-Peri/Epineurial_-NAF_epineurial|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.61e-04 | 199 | 24 | 3 | 9c2db0bb94cba71a3cc1827844da090e213e0258 | |
| ToppCell | Bronchial-10x5prime-Endothelial-Endothelia_vascular-VE_alveolar_capillary_Car4_aerocyte|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 1.61e-04 | 199 | 24 | 3 | 7ed541309808f15d65a9c4b26be2050e077539e6 | |
| ToppCell | Influenza-Influenza_Severe-Others-RBC|Influenza_Severe / Disease, condition lineage and cell class | 1.61e-04 | 199 | 24 | 3 | da0fec0a492bc3827d9066d2590bcd466cd45564 | |
| ToppCell | Tracheal-NucSeq-Stromal-Peri/Epineurial_|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.61e-04 | 199 | 24 | 3 | 3835452e4848d7f7dd8651c17b746b271ef39688 | |
| ToppCell | Parenchymal-10x5prime-Endothelial-Endothelia_vascular-VE_alveolar_capillary_Car4_aerocyte|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 1.61e-04 | 199 | 24 | 3 | 14a7c4cf4bb3d43fd32ec9cc74f6625b225ffaa1 | |
| ToppCell | Tracheal-10x3prime_v2-Stromal-Peri/Epineurial_|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations | 1.63e-04 | 200 | 24 | 3 | f7c3a8f5ac156c05ad7335d6d142c154c7d86449 | |
| ToppCell | Influenza-Influenza_Severe-Others|Influenza_Severe / Disease, condition lineage and cell class | 1.63e-04 | 200 | 24 | 3 | 8909da4f7da3bc469a2becb4cfa5c25012af5845 | |
| ToppCell | Tracheal-10x3prime_v2-Stromal-Peri/Epineurial_-NAF_epineurial|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations | 1.63e-04 | 200 | 24 | 3 | 24e13b6d9d2d8b29df1f02544ea9c50084d9e75c | |
| ToppCell | LV-03._Atrial_Cardiomyocyte|LV / Chamber and Cluster_Paper | 1.87e-03 | 120 | 24 | 2 | 3b77bd0e3630cdd45001cecf5e47660a90ebc92e | |
| ToppCell | TCGA-Bone_and_Soft_Tissue-Primary_Tumor-Sarcoma-Conventional_Leiomyosarcoma-1|TCGA-Bone_and_Soft_Tissue / Sample_Type by Project: Shred V9 | 2.00e-03 | 124 | 24 | 2 | 57f3335f751868a768934c757b06a6378148dc9e | |
| ToppCell | E16.5-samps-Mesenchymal-Myofibroblast-myofibroblast_-_immature|E16.5-samps / Age Group, Lineage, Cell class and subclass | 2.16e-03 | 129 | 24 | 2 | 5e4783cc63afdeaebdfaecb72f95f3efc8d3c4a3 | |
| ToppCell | COVID_vent-Lymphocytic-T_cell-Gamma_Delta_T_cell|COVID_vent / Disease condition, Lineage, Cell class and subclass | 2.26e-03 | 132 | 24 | 2 | dbc0a332fd8f63ebdcf9716e45d7f46f26509349 | |
| ToppCell | TCGA-Mesothelium-Primary_Tumor-Mesothelioma-Epitheliod-3|TCGA-Mesothelium / Sample_Type by Project: Shred V9 | 2.43e-03 | 137 | 24 | 2 | a1e34ebbeda3d5a4f14917282d44fcb4dcbf3133 | |
| ToppCell | saliva-Severe-critical_progression_d28-40-Lymphocytic-Lymphocytic_B-B_cell-B_c03-CD27-AIM2|Severe-critical_progression_d28-40 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 2.54e-03 | 140 | 24 | 2 | af9efcbaeeae69fcdac4a15fa244728b65915564 | |
| ToppCell | 3'-GW_trimst-1-SmallIntestine-Mesenchymal-myocytic-myofibroblast_(RSPO2+)|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.64e-03 | 143 | 24 | 2 | 39060dc1d87505a16e2df95140087c731f099570 | |
| ToppCell | 367C-Myeloid-Macrophage-SPP1+_Macrophage_2|Macrophage / Donor, Lineage, Cell class and subclass (all cells) | 2.68e-03 | 144 | 24 | 2 | 38ff324366ad5be626e3657c1e33277fc36ddd4c | |
| ToppCell | E18.5-samps-Mesenchymal-Pericyte-pericyte_C|E18.5-samps / Age Group, Lineage, Cell class and subclass | 2.94e-03 | 151 | 24 | 2 | 3f2abaa42876ce7a71d934ff16abe0cab0991a05 | |
| ToppCell | facs-Marrow-T_cells-18m-Lymphocytic-lymphoid_progenitor_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.98e-03 | 152 | 24 | 2 | acfafdb64bd5b0eb7371b04cfef51ed2798e9b30 | |
| ToppCell | facs-Marrow-T_cells-18m-Lymphocytic-common_lymphoid_progenitor_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.98e-03 | 152 | 24 | 2 | 9d6c88ceca0569dbeb12e488acec7fcb7f972f03 | |
| ToppCell | PBMC_fresh-frozen-Mild-Moderate_progression_d12-25-Lymphocytic-Lymphocytic_ILC-NK_cell-NK_c01-FCGR3A|Mild-Moderate_progression_d12-25 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 3.02e-03 | 153 | 24 | 2 | 4eb9c2d7e4b95d44198fc87dc115a08ef0153e26 | |
| ToppCell | PBMC_fresh-frozen-Mild-Moderate_progression_d12-25-Lymphocytic-Lymphocytic_ILC-NK_cell|Mild-Moderate_progression_d12-25 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 3.02e-03 | 153 | 24 | 2 | 26b5b45c117d155b028d298a0b93e16d343dca97 | |
| ToppCell | PBMC_fresh-frozen-Mild-Moderate_progression_d12-25-Lymphocytic-Lymphocytic_ILC|Mild-Moderate_progression_d12-25 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 3.02e-03 | 153 | 24 | 2 | 0f12e38f2cbf69a520764289b0aa4dedc645f714 | |
| ToppCell | Adult-Immune-dendritic_cell-D122|Adult / Lineage, Cell type, age group and donor | 3.06e-03 | 154 | 24 | 2 | 64a4686586d08b1e9632dde917b472ac660de2d3 | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Mesenchymal-Myocytic_interstitial_cell-Myofibroblast-|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 3.14e-03 | 156 | 24 | 2 | 363f1b661048d25895e2b8681c82894c957b29c0 | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Mesenchymal-Myocytic_interstitial_cell-Myofibroblast|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 3.14e-03 | 156 | 24 | 2 | d5207dbfbcfb885557ea1378dfe6a56d7102e94a | |
| ToppCell | LPS-IL1RA+antiTNF-Stromal_mesenchymal-Fibroblasts|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 3.18e-03 | 157 | 24 | 2 | f086753b51860e23f1275bd75e8802d2a7d7b70a | |
| ToppCell | Adult-Mesenchymal-vascular_smooth_muscle_cell-D231|Adult / Lineage, Cell type, age group and donor | 3.21e-03 | 158 | 24 | 2 | 8d64c0c9de910a3f4658778642d183c8b9b6f6a2 | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d12-22_with-steroid-Lymphocytic-Lymphocytic_ILC-NK_cell-NK_c02-NCAM1|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k) | 3.21e-03 | 158 | 24 | 2 | 4d997efc36fd8946775fe74dd9ac9ccd5ade64ff | |
| ToppCell | Control-Endothelial_cells-Inflamed_endothelial_cells|Control / group, cell type (main and fine annotations) | 3.29e-03 | 160 | 24 | 2 | 958256e3d3836160763b82bb48f794087918d935 | |
| ToppCell | TCGA-Bladder-Solid_Tissue_Normal|TCGA-Bladder / Sample_Type by Project: Shred V9 | 3.29e-03 | 160 | 24 | 2 | d6678996e12eaf2b735f1dfae32418cb2fabf268 | |
| ToppCell | TCGA-Bladder-Solid_Tissue_Normal-Urothelial_normal_tissue-Urothelial_normal_tissue|TCGA-Bladder / Sample_Type by Project: Shred V9 | 3.29e-03 | 160 | 24 | 2 | 8a41e2c96e0e170ac35daf6c403bf961b8d7c30b | |
| ToppCell | TCGA-Bladder-Solid_Tissue_Normal-Urothelial_normal_tissue|TCGA-Bladder / Sample_Type by Project: Shred V9 | 3.29e-03 | 160 | 24 | 2 | c8dc575562b463fd30832d322c28006f18f7ab9c | |
| ToppCell | Control|World / Disease group and Cell class | 3.34e-03 | 161 | 24 | 2 | e3e72cda7cc70f06d669f26ccf06d51346d7136f | |
| ToppCell | RV-13._Vascular_Smooth_Muscle|RV / Chamber and Cluster_Paper | 3.34e-03 | 161 | 24 | 2 | 47b3b7662cbb671ccc086dc0a0cabd65f63eb5a1 | |
| ToppCell | PND03-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_vascular-Pericyte-Pericyte_prolif|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 3.34e-03 | 161 | 24 | 2 | 82ed45f144a07856fe92d37426c5f92e259a03a9 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast-Collagen-high_Fibroblast-|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 3.38e-03 | 162 | 24 | 2 | 5f009b231f21861afee9cc0c569082e1135f929c | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast-Collagen-high_Fibroblast|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 3.38e-03 | 162 | 24 | 2 | b936f8040dcd4db621ccded19237af8df7d0ed6e | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Mesenchymal-Fibroblast-kidney_interstitial_fibroblast|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 3.38e-03 | 162 | 24 | 2 | 68c40d12689cc1b6c797e6e48173f0110f8144e4 | |
| ToppCell | facs-Trachea-24m-Mesenchymal-fibroblast-fibroblast_of_trachea-tracheal_fibroblast_l20-1|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 3.38e-03 | 162 | 24 | 2 | 56f1789e69a6cb29956e46aba92b290847327c1f | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Mesenchymal-Fibroblast-kidney_interstitial_fibroblast-kidney_interstitial_fibroblast_5|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 3.38e-03 | 162 | 24 | 2 | 735fa3f77b31a4189e431d05c326403c18cbbffb | |
| ToppCell | 3'-GW_trimst-1.5-SmallIntestine-Mesenchymal-myocytic-SMC_(PART1/CAPN3+)|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.42e-03 | 163 | 24 | 2 | e526104a3a574ee860078ce7c049e7fec9443f37 | |
| ToppCell | 368C-Epithelial_cells-Epithelial-A_(AT2)-|368C / Donor, Lineage, Cell class and subclass (all cells) | 3.46e-03 | 164 | 24 | 2 | 85f53d184fa70e3eb1af655807f32b17ddbfb304 | |
| ToppCell | Fetal_brain-organoid_Tanaka_cellReport-GW16-Mesenchymal-Cilia-bearing_cell|GW16 / Sample Type, Dataset, Time_group, and Cell type. | 3.46e-03 | 164 | 24 | 2 | 346e1530b4bf30adbcb2f7d64fdfb4cd8df69d7f | |
| ToppCell | 368C-Epithelial_cells-Epithelial-A_(AT2)|368C / Donor, Lineage, Cell class and subclass (all cells) | 3.46e-03 | 164 | 24 | 2 | 144ba070a1ede71684224cc6d4ead3b7e6a7b4c6 | |
| ToppCell | facs-Limb_Muscle-forelimb_and_hindlimb-18m-Mesenchymal-mesenchymal_stem_cell|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.50e-03 | 165 | 24 | 2 | f80665b75d43f1bf6919d59fc762e7e0bac653f2 | |
| ToppCell | 3'-GW_trimst-2-SmallIntestine-Epithelial-Tuft-related-Tuft|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.50e-03 | 165 | 24 | 2 | 34fd00be2b28716c871ad9fb356de84a299a0c01 | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d03-09-Lymphocytic-Lymphocytic_T-CD8-positive,_alpha-beta_T_cell-T_CD8_c06-TNF|Severe-critical_progression_d03-09 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 3.54e-03 | 166 | 24 | 2 | 217e0549f88819d02156ea64e8547b658b1c7aef | |
| ToppCell | TCGA-Mesothelium-Primary_Tumor-Mesothelioma-Biphasic|TCGA-Mesothelium / Sample_Type by Project: Shred V9 | 3.58e-03 | 167 | 24 | 2 | 9062577a4b7902c9a888d706589d1b05221c0fa8 | |
| ToppCell | Adult-Endothelial-alveolar_capillary_endothelial_cell_(Cap2;_aerocyte)-D231|Adult / Lineage, Cell type, age group and donor | 3.58e-03 | 167 | 24 | 2 | 5af9127bae05768a5164d5708a4ad37edca99324 | |
| ToppCell | PND03-Endothelial-Endothelial_blood-vessel-Microvascular_EC-CAP2-CAP2_prolif|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 3.62e-03 | 168 | 24 | 2 | c7021748003e5949f7caf7b3291c5bad294948c1 | |
| ToppCell | COVID-19-Heart-Neuronal|COVID-19 / Disease (COVID-19 only), tissue and cell type | 3.62e-03 | 168 | 24 | 2 | 88c2c574f428c2502b5fe099bd73b0758f668ef6 | |
| ToppCell | metastatic_Brain-B_lymphocytes-GrB-secreting_B_cells|metastatic_Brain / Location, Cell class and cell subclass | 3.67e-03 | 169 | 24 | 2 | 71f6761b9927f352e0ccc221ca373319915f4184 | |
| ToppCell | 3'-Broncho-tracheal-Endothelial-Blood_vessel_EC-capillary_endothelial_cell-EC_general_capillary-EC_general_capillary_L.2.0.0.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.67e-03 | 169 | 24 | 2 | 0d8b681404e18f3061d84425fb5f7d84e8e2b8d7 | |
| ToppCell | 368C-Myeloid-Macrophage-SPP1+_Macrophage_2|Myeloid / Donor, Lineage, Cell class and subclass (all cells) | 3.67e-03 | 169 | 24 | 2 | c6e5b179461996ced6c7621dc01cec00d401f4e8 | |
| ToppCell | E16.5-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_vascular-Pericyte-Pericyte_prolif|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 3.71e-03 | 170 | 24 | 2 | 1f994b690e881106a5d54b3080ccce6260bc3ac5 | |
| Drug | Chrysene-1,4-quinone [100900-16-1]; Down 200; 15.4uM; HL60; HG-U133A | 1.55e-06 | 193 | 24 | 5 | 1773_DN | |
| Drug | Dipyridamole [58-32-2]; Up 200; 8uM; HL60; HG-U133A | 4.12e-05 | 187 | 24 | 4 | 2017_UP | |
| Drug | chlorpromazine hydrochloride; Down 200; 1uM; PC3; HT_HG-U133A | 4.75e-05 | 194 | 24 | 4 | 1217_DN | |
| Drug | Hyoscyamine (L) [101-31-5]; Down 200; 13.8uM; HL60; HG-U133A | 4.75e-05 | 194 | 24 | 4 | 1424_DN | |
| Drug | Natamycin [7681-93-8]; Down 200; 6uM; PC3; HT_HG-U133A | 5.25e-05 | 199 | 24 | 4 | 5809_DN | |
| Drug | Iohexol [66108-95-0]; Up 200; 4.8uM; MCF7; HT_HG-U133A | 5.35e-05 | 200 | 24 | 4 | 3322_UP | |
| Disease | sex interaction measurement, inflammatory bowel disease | 9.17e-04 | 55 | 24 | 2 | EFO_0003767, EFO_0008343 | |
| Disease | MHC class I polypeptide-related sequence A measurement | 1.40e-03 | 68 | 24 | 2 | EFO_0008233 | |
| Disease | non-alcoholic fatty liver disease, type 2 diabetes mellitus | 3.60e-03 | 110 | 24 | 2 | EFO_0003095, MONDO_0005148 | |
| Disease | Takayasu arteritis | 6.42e-03 | 148 | 24 | 2 | EFO_1001857 | |
| Disease | breast cancer (is_implicated_in) | 6.58e-03 | 150 | 24 | 2 | DOID:1612 (is_implicated_in) | |
| Disease | autism spectrum disorder | 7.10e-03 | 156 | 24 | 2 | EFO_0003756 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| RPEGYNLKDEEGRLR | 126 | Q00005 | |
| PGRKRRRKGGDSDYD | 1286 | Q9UIF8 | |
| GGRVRDYLVRKRVGD | 141 | O00178 | |
| KEERDRYRGEPGEPG | 176 | P08572 | |
| ERFELGDGRKPGEAR | 241 | P21127 | |
| GPRKGDFTRQEYERR | 971 | Q9P1Y5 | |
| YLEDEGRSKARRRGP | 136 | Q96D70 | |
| GRGEDRRREDPAYTP | 151 | Q96D70 | |
| GYRVDGRRAGELRKI | 11 | Q9NPD3 | |
| RKPYEGRVEIQRAGE | 51 | P58215 | |
| RYERVGGGPKRLGRD | 91 | Q68CZ1 | |
| RIPKIRRDDGGGRRD | 681 | Q9P1Y6 | |
| YGEPREGGRRRVVLK | 96 | Q8NDZ4 | |
| EERDRASGYRKRGPK | 61 | O95931 | |
| IEEAPGAGGRRERRK | 341 | Q9Y613 | |
| KRRGRGTGEAEEEYV | 36 | Q13895 | |
| GDEAHRRRGEPPREY | 1376 | Q96JN8 | |
| VRGRRGERPDYKGEE | 26 | Q9UQ35 | |
| GERPDYKGEEELRRL | 31 | Q9UQ35 | |
| EAVRRGVVGPELYGR | 986 | P58107 | |
| GSEYEEIPKRRRQRG | 1091 | P48634 | |
| EDDYSPRERRGGGLR | 831 | Q14160 | |
| VELGYRGTGERVKRE | 46 | Q6V702 | |
| QYERKAERGAGERGP | 1126 | Q9BX66 | |
| RRDDRGGRQGYPREG | 921 | Q9H0D6 | |
| YKDRDGRPRAVRVGG | 1406 | P22105 | |
| YKDRDGRPQVVRVRG | 2986 | P22105 |